Trial intelligence / Profile preview

Low dose estrogen and cortical function in postmenopausal women

NCT01268046Phase 2Completed

Sponsor
Massachusetts General Hospital
Start
Nov 2009
Primary completion
Dec 2013
Modality
Hormone, Biologic
Countries
1
01

Overview

A Phase 2 trial of estradiol in menopause, Dementia, sponsored by Massachusetts General Hospital. Started Nov 2009; status: completed.

02

Drugs

estradiol
03

Conditions

menopauseDementia

Beyond the preview

Go deeper on NCT01268046.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01268046.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call